A positive serum MOG-IgG antibody test is pivotal for the diagnosis, setting MOGAD apart from MS and NMOSD, characterized by oligoclonal bands in cerebrospinal fluid (CSF) and AQP4 antibodies, respectively. This evidence concerns the gene MOG and myeloid sarcoma.